Tapewire

NYSE · USD

ABT

ABBOTT LABORATORIES

Export transactions ↓
Tapewire entity
2314
SEC CIK
0000001800
Parsed reports
2,562

Last 12 months

Inside the activity.

6 purchase rows · 11 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202610
Feb 202620
Mar 202606
Apr 202620
May 202610
Jun 202600
Jul 202600
Aug 202603
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 07, 2007 Filed Dec 11, 2007 00:37 UTC
LIEPMANN HOLGER AExecutive Vice President
Exercise / conversionCommon shares without par value 2,200 $45.45 $99,987.36
Disclosure

SEC source: 0001104659-07-088058 · a4.xml · nonDerivative · entry 2

LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,161

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 07, 2007 Filed Dec 11, 2007 00:37 UTC
LIEPMANN HOLGER AExecutive Vice President
Exercise / conversionCommon shares without par value 2,454 $41.03 $100,691.79
Disclosure

SEC source: 0001104659-07-088058 · a4.xml · nonDerivative · entry 1

LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,961

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 07, 2007 Filed Feb 8, 2008 20:46 UTC
WHITE MILES DDirector · Chairman and CEO
GiftCommon shares without par value 16,025 $0.00 $0.00
Disclosure

SEC source: 0001104659-08-008542 · a4.xml · nonDerivative · entry 2

WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,037,850

Read SEC document
December 07, 2007 Filed Feb 8, 2008 20:48 UTC
Landgraf John CSenior Vice President
GiftCommon shares without par value 400 $0.00 $0.00
Disclosure

SEC source: 0001104659-08-008546 · a4.xml · nonDerivative · entry 4

Landgraf John C · CIK 0001298968 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Indirect · By self for son

Disclosed balance after: 1,296

F3 · balance_after: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16a-11.

F4 · balance_after: Reporting person disclaims beneficial ownership of all securities held by his son.

Read SEC document
December 07, 2007 Filed Feb 8, 2008 20:48 UTC
Landgraf John CSenior Vice President
GiftCommon shares without par value 1,165 $0.00 $0.00
Disclosure

SEC source: 0001104659-08-008546 · a4.xml · nonDerivative · entry 1

Landgraf John C · CIK 0001298968 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,207

Read SEC document
December 06, 2007 Filed Dec 10, 2007 23:53 UTC
Schumacher Laura JExecutive Vice President
GrantOption (right to buy) · Derivative 1,719 $0.00 Strike: $58.16 $0.00
Disclosure

SEC source: 0001104659-07-088054 · a4.xml · derivative · entry 17

Schumacher Laura J · CIK 0001319245 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,719

Underlying: Common shares · 1,719 shares

Expires 2011-02-08

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

Read SEC document
December 06, 2007 Filed Dec 10, 2007 23:53 UTC
Schumacher Laura JExecutive Vice President
GrantOption (right to buy) · Derivative 1,731 $0.00 Strike: $58.16 $0.00
Disclosure

SEC source: 0001104659-07-088054 · a4.xml · derivative · entry 16

Schumacher Laura J · CIK 0001319245 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,731

Underlying: Common shares · 1,731 shares

Expires 2014-02-19

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

Read SEC document
December 06, 2007 Filed Dec 10, 2007 23:53 UTC
Schumacher Laura JExecutive Vice President
GrantOption (right to buy) · Derivative 2,197 $0.00 Strike: $58.16 $0.00
Disclosure

SEC source: 0001104659-07-088054 · a4.xml · derivative · entry 15

Schumacher Laura J · CIK 0001319245 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,197

Underlying: Common shares · 2,197 shares

Expires 2009-02-11

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

Read SEC document
December 06, 2007 Filed Dec 10, 2007 23:53 UTC
Schumacher Laura JExecutive Vice President
GrantOption (right to buy) · Derivative 1,742 $0.00 Strike: $58.16 $0.00
Disclosure

SEC source: 0001104659-07-088054 · a4.xml · derivative · entry 14

Schumacher Laura J · CIK 0001319245 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,742

Underlying: Common shares · 1,742 shares

Expires 2013-02-13

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

Read SEC document
December 06, 2007 Filed Dec 10, 2007 23:53 UTC
Schumacher Laura JExecutive Vice President
GrantOption (right to buy) · Derivative 1,857 $0.00 Strike: $58.16 $0.00
Disclosure

SEC source: 0001104659-07-088054 · a4.xml · derivative · entry 13

Schumacher Laura J · CIK 0001319245 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,857

Underlying: Common shares · 1,857 shares

Expires 2010-02-10

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

Read SEC document
December 06, 2007 Filed Dec 10, 2007 23:53 UTC
Schumacher Laura JExecutive Vice President
Exercise / conversionOption (right to buy) · Derivative 2,200 $0.00 Strike: $45.45 $0.00
Disclosure

SEC source: 0001104659-07-088054 · a4.xml · derivative · entry 12

Schumacher Laura J · CIK 0001319245 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,228

Underlying: Common shares · 2,200 shares

Expires 2011-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

Read SEC document
December 06, 2007 Filed Dec 10, 2007 23:53 UTC
Schumacher Laura JExecutive Vice President
Exercise / conversionOption (right to buy) · Derivative 2,454 $0.00 Strike: $41.03 $0.00
Disclosure

SEC source: 0001104659-07-088054 · a4.xml · derivative · entry 11

Schumacher Laura J · CIK 0001319245 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,146

Underlying: Common shares · 2,454 shares

Expires 2014-02-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

Read SEC document
December 06, 2007 Filed Dec 10, 2007 23:53 UTC
Schumacher Laura JExecutive Vice President
Exercise / conversionOption (right to buy) · Derivative 3,008 $0.00 Strike: $42.50 $0.00
Disclosure

SEC source: 0001104659-07-088054 · a4.xml · derivative · entry 10

Schumacher Laura J · CIK 0001319245 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,482

Underlying: Common shares · 3,008 shares

Expires 2009-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

Read SEC document
December 06, 2007 Filed Dec 10, 2007 23:53 UTC
Schumacher Laura JExecutive Vice President
Exercise / conversionOption (right to buy) · Derivative 3,050 $0.00 Strike: $33.23 $0.00
Disclosure

SEC source: 0001104659-07-088054 · a4.xml · derivative · entry 9

Schumacher Laura J · CIK 0001319245 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common shares · 3,050 shares

Expires 2013-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

Read SEC document
December 06, 2007 Filed Dec 10, 2007 23:53 UTC
Schumacher Laura JExecutive Vice President
Exercise / conversionOption (right to buy) · Derivative 3,312 $0.00 Strike: $32.61 $0.00
Disclosure

SEC source: 0001104659-07-088054 · a4.xml · derivative · entry 8

Schumacher Laura J · CIK 0001319245 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common shares · 3,312 shares

Expires 2010-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

Read SEC document
December 06, 2007 Filed Dec 10, 2007 23:53 UTC
Schumacher Laura JExecutive Vice President
Tax withholdingCommon shares without par value 9,246 $58.16 $537,747.36
Disclosure

SEC source: 0001104659-07-088054 · a4.xml · nonDerivative · entry 6

Schumacher Laura J · CIK 0001319245 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,302

Read SEC document
December 06, 2007 Filed Dec 10, 2007 23:53 UTC
Schumacher Laura JExecutive Vice President
Exercise / conversionCommon shares without par value 2,200 $45.45 $99,987.36
Disclosure

SEC source: 0001104659-07-088054 · a4.xml · nonDerivative · entry 5

Schumacher Laura J · CIK 0001319245 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,548

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 06, 2007 Filed Dec 10, 2007 23:53 UTC
Schumacher Laura JExecutive Vice President
Exercise / conversionCommon shares without par value 2,454 $41.03 $100,691.79
Disclosure

SEC source: 0001104659-07-088054 · a4.xml · nonDerivative · entry 4

Schumacher Laura J · CIK 0001319245 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,348

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 06, 2007 Filed Dec 10, 2007 23:53 UTC
Schumacher Laura JExecutive Vice President
Exercise / conversionCommon shares without par value 3,008 $42.50 $127,833.38
Disclosure

SEC source: 0001104659-07-088054 · a4.xml · nonDerivative · entry 3

Schumacher Laura J · CIK 0001319245 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,894

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 06, 2007 Filed Dec 10, 2007 23:53 UTC
Schumacher Laura JExecutive Vice President
Exercise / conversionCommon shares without par value 3,050 $33.23 $101,355.77
Disclosure

SEC source: 0001104659-07-088054 · a4.xml · nonDerivative · entry 2

Schumacher Laura J · CIK 0001319245 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,886

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 06, 2007 Filed Dec 10, 2007 23:53 UTC
Schumacher Laura JExecutive Vice President
Exercise / conversionCommon shares without par value 3,312 $32.61 $108,007.96
Disclosure

SEC source: 0001104659-07-088054 · a4.xml · nonDerivative · entry 1

Schumacher Laura J · CIK 0001319245 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,836

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 03, 2007 Filed Dec 5, 2007 23:38 UTC
Fussell Stephen RSenior Vice President
GrantOption (right to buy) · Derivative 1,196 $0.00 Strike: $57.51 $0.00
Disclosure

SEC source: 0001104659-07-087206 · a4.xml · derivative · entry 5

Fussell Stephen R · CIK 0001327700 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,196

Underlying: Common shares · 1,196 shares

Expires 2009-02-11

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature in a transaction exempt from Section 16(b) under Rule 16b-3.

Read SEC document
December 03, 2007 Filed Dec 5, 2007 23:38 UTC
Fussell Stephen RSenior Vice President
Exercise / conversionOption (right to buy) · Derivative 1,420 $0.00 Strike: $42.50 $0.00
Disclosure

SEC source: 0001104659-07-087206 · a4.xml · derivative · entry 4

Fussell Stephen R · CIK 0001327700 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,485

Underlying: Common shares · 1,420 shares

Expires 2009-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature in a transaction exempt from Section 16(b) under Rule 16b-3.

Read SEC document
December 03, 2007 Filed Dec 5, 2007 23:38 UTC
Fussell Stephen RSenior Vice President
Tax withholdingCommon shares without par value 1,196 $57.51 $68,781.96
Disclosure

SEC source: 0001104659-07-087206 · a4.xml · nonDerivative · entry 2

Fussell Stephen R · CIK 0001327700 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,143

Read SEC document
December 03, 2007 Filed Dec 5, 2007 23:38 UTC
Fussell Stephen RSenior Vice President
Exercise / conversionCommon shares without par value 1,420 $42.50 $60,346.88
Disclosure

SEC source: 0001104659-07-087206 · a4.xml · nonDerivative · entry 1

Fussell Stephen R · CIK 0001327700 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,339

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 30, 2007 Filed Dec 4, 2007 22:13 UTC
FREYMAN THOMAS CExecutive Vice President
GrantOption (right to buy) · Derivative 56,835 $0.00 Strike: $57.00 $0.00
Disclosure

SEC source: 0001104659-07-086861 · a4.xml · derivative · entry 8

FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,835

Underlying: common shares · 56,835 shares

Expires 2011-02-08

F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

Read SEC document
November 30, 2007 Filed Dec 4, 2007 22:13 UTC
FREYMAN THOMAS CExecutive Vice President
Exercise / conversionOption (right to buy) · Derivative 64,784 $0.00 Strike: $45.45 $0.00
Disclosure

SEC source: 0001104659-07-086861 · a4.xml · derivative · entry 7

FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: common shares · 64,784 shares

Expires 2011-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

Read SEC document
November 30, 2007 Filed Dec 4, 2007 22:13 UTC
FREYMAN THOMAS CExecutive Vice President
Tax withholdingCommon shares without par value 56,835 $57.00 $3,239,595.00
Disclosure

SEC source: 0001104659-07-086861 · a4.xml · nonDerivative · entry 2

FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 290,198

Read SEC document
November 30, 2007 Filed Dec 4, 2007 22:13 UTC
FREYMAN THOMAS CExecutive Vice President
Exercise / conversionCommon shares without par value 64,784 $45.45 $2,944,355.06
Disclosure

SEC source: 0001104659-07-086861 · a4.xml · nonDerivative · entry 1

FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 347,033

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 30, 2007 Filed Dec 4, 2007 22:14 UTC
LINDER GREG WVice President
GrantOption (right to buy) · Derivative 45,893 $0.00 Strike: $57.00 $0.00
Disclosure

SEC source: 0001104659-07-086863 · a4.xml · derivative · entry 5

LINDER GREG W · CIK 0001239128 · Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,893

Underlying: common shares · 45,893 shares

Expires 2011-02-08

F2 · security: Employee stock option including a replacement option feature granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
November 30, 2007 Filed Dec 4, 2007 22:14 UTC
LINDER GREG WVice President
Exercise / conversionOption (right to buy) · Derivative 52,312 $0.00 Strike: $45.45 $0.00
Disclosure

SEC source: 0001104659-07-086863 · a4.xml · derivative · entry 4

LINDER GREG W · CIK 0001239128 · Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,530

Underlying: common shares · 52,312 shares

Expires 2011-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option including a replacement option feature granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
November 30, 2007 Filed Dec 4, 2007 22:14 UTC
LINDER GREG WVice President
Tax withholdingCommon shares without par value 45,893 $57.00 $2,615,901.00
Disclosure

SEC source: 0001104659-07-086863 · a4.xml · nonDerivative · entry 2

LINDER GREG W · CIK 0001239128 · Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,532

Read SEC document
November 30, 2007 Filed Dec 4, 2007 22:14 UTC
LINDER GREG WVice President
Exercise / conversionCommon shares without par value 52,312 $45.45 $2,377,517.63
Disclosure

SEC source: 0001104659-07-086863 · a4.xml · nonDerivative · entry 1

LINDER GREG W · CIK 0001239128 · Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 181,425

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 30, 2007 Filed Dec 4, 2007 22:16 UTC
Landgraf John CSenior Vice President
GrantOption (right to buy) · Derivative 13,782 $0.00 Strike: $57.00 $0.00
Disclosure

SEC source: 0001104659-07-086864 · a4.xml · derivative · entry 7

Landgraf John C · CIK 0001298968 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,782

Underlying: Common Shares · 13,782 shares

Expires 2011-02-08

F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

Read SEC document
November 30, 2007 Filed Dec 4, 2007 22:16 UTC
Landgraf John CSenior Vice President
Exercise / conversionOption (right to buy) · Derivative 15,710 $0.00 Strike: $45.45 $0.00
Disclosure

SEC source: 0001104659-07-086864 · a4.xml · derivative · entry 6

Landgraf John C · CIK 0001298968 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,851

Underlying: Common Shares · 15,710 shares

Expires 2011-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

Read SEC document
November 30, 2007 Filed Dec 4, 2007 22:16 UTC
Landgraf John CSenior Vice President
Tax withholdingCommon shares without par value 13,782 $57.00 $785,574.00
Disclosure

SEC source: 0001104659-07-086864 · a4.xml · nonDerivative · entry 2

Landgraf John C · CIK 0001298968 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,372

Read SEC document
November 30, 2007 Filed Dec 4, 2007 22:16 UTC
Landgraf John CSenior Vice President
Exercise / conversionCommon shares without par value 15,710 $45.45 $714,000.65
Disclosure

SEC source: 0001104659-07-086864 · a4.xml · nonDerivative · entry 1

Landgraf John C · CIK 0001298968 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,154

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 26, 2007 Filed Nov 28, 2007 16:33 UTC
Chen Thomas FSenior Vice President
SaleCommon shares without par value 2,442 $55.50 $135,531.00
Disclosure

SEC source: 0001104659-07-085526 · a4.xml · nonDerivative · entry 1

Chen Thomas F · CIK 0001360147 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,070

Read SEC document
November 26, 2007 Filed Jan 2, 2008 23:09 UTC GiftCommon shares without par value 29,434 $0.00 $0.00
Disclosure

SEC source: 0001104659-08-000231 · a4.xml · nonDerivative · entry 1

FULLER H LAURANCE · CIK 0001187553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,946

Read SEC document
November 20, 2007 Filed Nov 21, 2007 15:27 UTC
Chen Thomas FSenior Vice President
SaleCommon shares without par value 10,000 $55.50 $555,000.00
Disclosure

SEC source: 0001104659-07-084558 · a4.xml · nonDerivative · entry 1

Chen Thomas F · CIK 0001360147 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,512

Read SEC document
November 16, 2007 Filed Feb 8, 2008 20:46 UTC
WHITE MILES DDirector · Chairman and CEO
GiftCommon shares without par value 413 $0.00 $0.00
Disclosure

SEC source: 0001104659-08-008542 · a4.xml · nonDerivative · entry 8

WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By son

Disclosed balance after: 5,168

F2 · ownership.nature: The reporting person disclaims beneficial ownership of all securities held by his wife and sons.

Read SEC document
November 16, 2007 Filed Feb 8, 2008 20:46 UTC
WHITE MILES DDirector · Chairman and CEO
GiftCommon shares without par value 413 $0.00 $0.00
Disclosure

SEC source: 0001104659-08-008542 · a4.xml · nonDerivative · entry 7

WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By son

Disclosed balance after: 5,168

F2 · ownership.nature: The reporting person disclaims beneficial ownership of all securities held by his wife and sons.

Read SEC document
November 16, 2007 Filed Feb 8, 2008 20:46 UTC
WHITE MILES DDirector · Chairman and CEO
GiftCommon shares without par value 642 $0.00 $0.00
Disclosure

SEC source: 0001104659-08-008542 · a4.xml · nonDerivative · entry 6

WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By wife

Disclosed balance after: 0

F2 · ownership.nature: The reporting person disclaims beneficial ownership of all securities held by his wife and sons.

Read SEC document
November 16, 2007 Filed Feb 8, 2008 20:46 UTC
WHITE MILES DDirector · Chairman and CEO
GiftCommon shares without par value 642 $0.00 $0.00
Disclosure

SEC source: 0001104659-08-008542 · a4.xml · nonDerivative · entry 5

WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By wife

Disclosed balance after: 642

F2 · ownership.nature: The reporting person disclaims beneficial ownership of all securities held by his wife and sons.

Read SEC document
November 16, 2007 Filed Feb 8, 2008 20:46 UTC
WHITE MILES DDirector · Chairman and CEO
GiftCommon shares without par value 1,239 $0.00 $0.00
Disclosure

SEC source: 0001104659-08-008542 · a4.xml · nonDerivative · entry 1

WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,053,875

Read SEC document
November 13, 2007 Filed Nov 15, 2007 16:52 UTC
FREYMAN THOMAS CExecutive Vice President
GrantOption (right to buy) · Derivative 25,701 $0.00 Strike: $54.67 $0.00
Disclosure

SEC source: 0001104659-07-083396 · a4.xml · derivative · entry 8

FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,701

Underlying: Common shares · 25,701 shares

Expires 2013-02-13

F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3.

Read SEC document
November 13, 2007 Filed Nov 15, 2007 16:52 UTC
FREYMAN THOMAS CExecutive Vice President
Exercise / conversionOption (right to buy) · Derivative 29,245 $0.00 Strike: $43.73 $0.00
Disclosure

SEC source: 0001104659-07-083396 · a4.xml · derivative · entry 7

FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common shares · 29,245 shares

Expires 2013-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3.

Read SEC document
November 13, 2007 Filed Nov 15, 2007 16:52 UTC
FREYMAN THOMAS CExecutive Vice President
Tax withholdingCommon shares without par value 25,701 $54.67 $1,405,073.67
Disclosure

SEC source: 0001104659-07-083396 · a4.xml · nonDerivative · entry 2

FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 282,249

Read SEC document
November 13, 2007 Filed Nov 15, 2007 16:52 UTC
FREYMAN THOMAS CExecutive Vice President
Exercise / conversionCommon shares without par value 29,245 $43.73 $1,278,883.85
Disclosure

SEC source: 0001104659-07-083396 · a4.xml · nonDerivative · entry 1

FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,950

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 12, 2007 Filed Nov 14, 2007 23:38 UTC
Chen Thomas FSenior Vice President
SaleCommon shares without par value 10,000 $55.00 $550,000.00
Disclosure

SEC source: 0001104659-07-083234 · a4.xml · nonDerivative · entry 1

Chen Thomas F · CIK 0001360147 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,512

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.